Although the guidelines for the treatment of anemia in patients with CKD favor a relatively liberal use of intravenous iron with the purpose of strengthening the action of erythropoietin (EPO), they fail to consider that high ferritin levels may induce hemosiderosis. This evidence concerns the gene EPO and anemia.